Therapeutic binding molecules

Details for Australian Patent Application No. 2002231795 (hide)

Owner NOVARTIS AG

Inventors Aszodi, Andras; Hall, Bruce, M.; Saldanha, Jose, W.; Aversa, Gregorio; Carballido Herrera, Jose, M.; Kolbinger, Frank

Agent Davies Collison Cave

Pub. Number AU-A-2002231795

PCT Pub. Number WO2002/072832

Priority 0103389.3 12.02.01 GB

Filing date 11 February 2002

Wipo publication date 24 September 2002

International Classifications

C12N 015/13 Mutation or genetic engineering - Immunoglobulins

A61P 037/00 Drugs for immunological or allergic disorders

C07K 016/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 015/79 Mutation or genetic engineering - Vectors or expression systems specially adapted for eukaryotic hosts

C12N 015/10 Mutation or genetic engineering - Processes for the isolation, preparation or purification of DNA or RNA

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

20 March 2003 Application Open to Public Inspection

  Published as AU-A-2002231795

28 September 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002231796-PRINTED CIRCUIT BOARD AND CONNECTOR ASSEMBLY

2002231794-SCREW EXTRUDER WITH IMPROVED MIXING PINS